On The Fly
| ShowHide Related Items >><< ADPT Adaptive Biotechnologies - 01/11/21
- Adaptive in pact with AstraZeneca to investigate use of immunoSEQ T-MAP
- 12/06/20
- Adaptive announces new data demonstrating impact of clonoSEQ Assay
- 11/13/20
- Adaptive Biotechnologies announces preliminary data on T-Detect Assay
- 08/06/20
- Adaptive Biotechnologies receives expanded FDA clearance for clonoSEQ Assay
- 01/15/21
- REV Group CFO buys 15K shares of common stock
- 01/07/21
- REV Group falls -10.0%
- 09/09/20
- REV Group rises 7.8%
- 08/20/20
- Kaman CEO Neal Keating to retire, Ian Walsh to succeed
- 01/15/21
- Steel Partners rises 16.2%
- 01/15/21
- Steel Partners rises 15.7%
- 01/14/21
- Steel Partners director buys 77.3K shares of common stock
- 12/30/20
- Steel Partners rises 21.3%
- 01/11/21
- B. Riley Financial to acquire remaining shares of National Holdings for $3.25
- 01/11/21
- B. Riley Financial to acquire remaining shares of National Holdings for $3.25
- 12/17/20
- B. Riley Financial announces strategic investment in Lingo Communications
- 12/02/20
- B. Riley Financial acquires interest in Justice brand assets
- $261.66 /
+10.13 (+4.03%) - 01/11/21
- Facebook to remove content containing phrase 'stop the steal'
- 01/11/21
- Airbnb says its PAC will 'withhold support' from those who opposed certification
- 01/11/21
- Facebook names Roy Austin as VP of Civil RIghts, deputy general counsel
- 01/10/21
- Fly Intel: Top five weekend stock stories
- 01/08/21
- Neurocrine plans to initiate seven mid-to-late stage clinical studies in 2021
- 12/22/20
- Voyager says clinical hold placed on RESTOR-1 clinical trial of NBIb-1817
- 11/09/20
- Neurocrine falls 13% to $89.55 after reporting mixed Q3 results
- 11/09/20
- Neurocrine sees FY20 combined GAAP R&D and SG&A expenses $880M-$900M
- $47.03 /
+4.385 (+10.28%) - 01/12/21
- One Medical extends public COVID-19 vaccination effors
- 12/30/20
- 1Life Healthcare begins COVID-19 vaccination in San Francisco
- 09/30/20
- One Medical, Houston Methodist to partner on coordinated care in Houston
- 09/09/20
- One Medical, Ohio State Wexner Medical Center announce partnership
ADPT Adaptive Biotechnologies - 06:48 Today BTIG
- Adaptive Biotechnologies price target raised to $74 from $66 at BTIG
- 12/17/20 BTIG
- BTIG positive on select healthcare diagnostic/tools names as '2021 Top Picks'
- 11/12/20 BTIG
- Adaptive Biotechnologies price target raised to $63 from $60 at BTIG
- 11/11/20 JPMorgan
- Adaptive Biotechnologies price target raised to $60 from $50 at JPMorgan
- 01/08/21 Baird
- REV Group result pretty much as expected, says Baird
- 12/17/20 Baird
- REV Q4 results delay could portend impending portfolio realignment, says Baird
- 12/15/20 Morgan Stanley
- REV Group upgraded to Equal Weight on improved RV outlook at Morgan Stanley
- 12/15/20 Morgan Stanley
- REV Group upgraded to Equal Weight from Underweight at Morgan Stanley
- $261.66 /
+10.13 (+4.03%) - 10:13 Today JPMorgan
- JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
- 09:52 Today
- Fly Intel: Top five analyst upgrades
- 07:28 Today KeyBanc
- Facebook price target raised to $345 from $340 at KeyBanc
- 05:02 Today BMO Capital
- Facebook upgraded to Outperform from Market Perform at BMO Capital
- 12/29/20 Cantor Fitzgerald
- Neurocrine price target lowered to $121 from $168 at Cantor Fitzgerald
- 12/07/20 Wedbush
- Neurocrine price target lowered to $121 from $129 at Wedbush
- 11/12/20 Canaccord
- Neurocrine price target lowered to $122 from $145 at Canaccord
- 11/10/20 SVB Leerink
- Neurocrine price target lowered to $100 from $120 at SVB Leerink
- $47.03 /
+4.385 (+10.28%) - 10:07 Today JPMorgan
- Teladoc remains top 2021 healthcare technology pick at JPMorgan
- 01/08/21 Piper Sandler
- 1Life Healthcare price target raised to $51 from $44 at Piper Sandler
- 01/07/21 Canaccord
- 1Life Healthcare price target raised to $50 from $46 at Canaccord
- 01/06/21 BTIG
- 1Life Healthcare initiated with a Neutral at BTIG
ADPT Adaptive Biotechnologies - 11/10/20
- Adaptive Biotechnologies reports Q3 EPS (27c), consensus (28c)
- 08/10/20
- Adaptive Biotechnologies reports Q2 EPS (26c), consensus (28c)
- 01/07/21
- REV Group reports Q4 adjusted EPS 19c, consensus 16c
- 12/17/20
- REV Group reports preliminary Q4 revenue $616M, consensus $614.14M
- 09/09/20
- REV Group reports Q3 adj. EPS 10c, consensus 0c
- 11/03/20
- Steel Partners reports Q3 adj. EBITDA $73.3M vs. $59.2M last year
- 01/12/21
- B. Riley Financial sees FY20 EPS $7.20-$7.39
- 01/12/21
- B. Riley Financial raises Q4 EPS view to $6.18-$6.38 from $4.15-$4.27
- $261.66 /
+10.13 (+4.03%) - 10/29/20
- Facebook sees Q4 ad revenue growth rate higher than Q3
- 10/29/20
- Facebook reports Q3 EPS $2.71, consensus $1.91
- 10/29/20
- Notable companies reporting after market close
- 07/30/20
- Facebook reports Q2 EPS $1.80, consensus $1.39
- 01/08/21
- Neurocrine sees Q4 INGREZZA net product sales approximately $240M
- 11/09/20
- Neurocrine reports Q3 non-GAAP EPS 97c, consensus 22c
- 08/03/20
- Neurocrine reports Q2 non-GAAP EPS $1.42, consensus 73c
- $47.03 /
+4.385 (+10.28%) - 11/10/20
- 1Life Healthcare sees FY20 revenue $362M-$367M, consensus $333.88M
- 11/10/20
- 1Life Healthcare sees Q4 revenue $104M-$109M, consensus $90.9M
- 11/10/20
- 1Life Healthcare reports Q3 EPS (13c), consensus (19c)
- 08/12/20
- One Medical sees Q3 revenue $84M-$89M, consensus $74.6M
|
Recommendations
| ShowHide Related Items >><< - 11/09/20 Goldman Sachs
- Icade upgraded to Neutral from Sell at Goldman Sachs
- 10/23/20 Deutsche Bank
- Icade price target lowered to EUR 74 from EUR 99 at Deutsche Bank
- 10/20/20 BofA
- Icade upgraded to Buy from Neutral at BofA
- 09/03/20 Morgan Stanley
- Icade price target lowered to EUR 60 from EUR 75 at Morgan Stanley
|
On The Fly
|
Shares of Lumentum (LITE)… ShowHide Related Items >><< - 06:35 Today
- Lumentum to acquire Coherent in $5.7B cash and stock transaction, sees accretion
- 11/16/20
- Lumentum acquires TriLumina assets; terms not disclosed
- 09/04/20
- FCC says U.S. rural telecom networks need $1.84B to remove Huawei, ZTE equipment
- 08/11/20
- Lumentum CEO says 'better than projected results' in Q4
- $199.54 /
+47.62 (+31.35%) - 06:35 Today
- Lumentum to acquire Coherent in $5.7B cash and stock transaction, sees accretion
- 12/16/20
- Coherent, II-VI enter supply agreement
- 12/16/20
- II-VI, Coherent enter supply agreement for automotive laser welding solutions
- 11/10/20
- Coherent CEO says 'cautiously optimistic on 5G upgrade cycle
- 01/17/21
- Fly Intel: Top five weekend stock stories
- 01/15/21
- VirnetX says court affirms jury award of $502.8M against Apple
- 01/15/21
- VirnetX jumps after court denies Apple motion for new patent trial
- 01/14/21
- Abbott launches NeuroSphere myPath digital health app
- 14:54 Today Craig-Hallum
- Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum
- 01/12/21 MKM Partners
- Lumentum price target raised to $138 from $120 at MKM Partners
- 01/12/21 Susquehanna
- Susquehanna names top five M&A candidates in Semi space
- 01/11/21 B. Riley Securities
- Lumentum price target raised to $123 from $101 at B. Riley Securities
- $199.54 /
+47.62 (+31.35%) - 14:54 Today Craig-Hallum
- Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum
- 01/12/21 Barclays
- Coherent downgraded to Underweight from Equal Weight at Barclays
- 11/12/20 Longbow
- Coherent downgraded to Neutral ahead of transition year at Longbow
- 11/12/20 Longbow
- Coherent downgraded to Neutral from Buy at Longbow
- 14:54 Today Craig-Hallum
- Lumentum acquisition of Coherent 'a good fit in many ways,' says Craig-Hallum
- 05:02 Today BMO Capital
- Facebook upgraded to Outperform from Market Perform at BMO Capital
- 01/15/21 Goldman Sachs
- Goldman Sachs raises short-term forecasts for Apple, maintains Sell rating
- 01/15/21 Loop Capital
- Apple price target raised to $155 from $131 at Loop Capital
- 06:38 Today
- Lumentum reports preliminary Q2 EPS $1.91-$1.99, consensus $1.82
- 11/02/20
- Lumentum sees Q2 non-GAAP EPS $1.70-$1.90, consensus $1.60
- 11/02/20
- Lumentum reports Q1 non-GAAP EPS $1.78, consensus $1.47
- 08/11/20
- Lumentum sees Q1 adjusted EPS $1.40-$1.55, consensus $1.33
- $199.54 /
+47.62 (+31.35%) - 06:40 Today
- Coherent reports preliminary Q1 revenue $325M-$327M, consensus $313.09M
- 11/10/20
- Coherent sees Q1 revenue $300M-$320M, consensus $341.28M
- 11/10/20
- Coherent reports Q4 adjusted EPS $1.01, consensus 80c
- 08/04/20
- Coherent sees Q4 revenue $290M-$320M, consensus $325.49M
- 10/29/20
- Apple says Q4 results were ahead of expectations
- 10/29/20
- Apple reports Q4 Services revenue $14.55B vs. $12.51B last year
- 10/29/20
- Apple reports Q4 iPhone revenue $24.44B vs. $33.36B last year
- 10/29/20
- Apple reports Q4 EPS 73c, consensus 70c
- 09:57 Today
- NeoPhotonics speculated as potential takeover target at Dealreporter
- 01/18/21
- Lumentum in advanced talks to acquire Coherent, WSJ reports
- 12/03/20
- U.S. in talks with Huawei CFO to settle charges, WSJ reports
- 11/23/20
- U.K. considers Huawei installation ban in 2021, Bloomberg says
- $199.54 /
+47.62 (+31.35%) - 09:57 Today
- NeoPhotonics speculated as potential takeover target at Dealreporter
- 01/18/21
- Lumentum in advanced talks to acquire Coherent, WSJ reports
- 01/17/21
- Apple considering foldable iPhone, minor changes for 2021 models, Bloomberg says
- 01/17/21
- Google might face 4th government suit over business practices, Reuters says
- 01/15/21
- Apple to re-close stores in Texas, North Carolina, Georgia, Bloomberg says
- 01/15/21
- Apple to challenge Spotify with podcast subscription service, Information says
- 12:16 Today
- Fly Intel: Wall Street's top stories at midday
- 09:17 Today
- Fly Intel: Pre-market Movers
- 01/12/21
- On, Lumentum seen among top semiconductors takeout candidates for 2021
- 11/02/20
- Fly Intel: Pre-market Movers
- $199.54 /
+47.62 (+31.35%) - 12:16 Today
- Fly Intel: Wall Street's top stories at midday
- 09:17 Today
- Fly Intel: Pre-market Movers
- 10:05 Today
- Facebook upgrade, Roku initiation among today's top calls on Wall Street
- 01/15/21
- Fly Intel: Wall Street's top stories for Friday
- 01/15/21
- Spotify plunges after downgrade, report of Apple podcast ambitions
- 01/13/21
- Fly Intel: Wall Street's top stories for Wednesday
- 01/05/21
- Lumentum call volume above normal and directionally bullish
- 08/17/20
- Lumentum put volume heavy and directionally bearish
- 08/03/20
- Lumentum call volume above normal and directionally bullish
- 08:55 Today
- Notable open interest changes for January 19th
- 01/15/21
- Notable open interest changes for January 15th
- 01/14/21
- Notable open interest changes for January 14th
- 01/13/21
- Notable open interest changes for January 13th
|
Recommendations
| ShowHide Related Items >><< - 12/15/20
- Galapagos to assume development, manufacturing, other rights for Jyseleca
- 12/15/20
- Gilead will not pursue FDA approval of Jyseleca for RA
- 12/01/20
- Galapagos announces 1st dosing in Mangrove trial in GLPG2737 with ADPKD patient
- 11/30/20
- Galapagos presents results with GLPG1205 in IPF patients in Pinta trial
- 05:55 Today Morgan Stanley
- Galapagos upgraded to Overweight from Equal Weight at Morgan Stanley
- 12/18/20 Truist
- Gilead price target lowered to $62 from $67 at Truist
- 12/17/20 Maxim
- Galapagos price target lowered to $140 from $170 at Maxim
- 12/17/20 Oppenheimer
- Gilead price target lowered to $100 from $105 at Oppenheimer
- 08/06/20
- Galapagos reports first half EPS EUR (2.55) vs. (1.76) last year
- 12/16/20
- Fly Intel: Wall Street's top stories for Wednesday
- 12/16/20
- Fly Intel: Wall Street's top stories at midday
- 12/15/20
- Fly Intel: After-Hours Movers
- 08/19/20
- Fly Intel: Wall Street's top stories for Wednesday
|
Periodicals
| ShowHide Related Items >><< - 01/11/21
- Facebook to remove content containing phrase 'stop the steal'
- 01/11/21
- Airbnb says its PAC will 'withhold support' from those who opposed certification
- 01/11/21
- Facebook names Roy Austin as VP of Civil RIghts, deputy general counsel
- 01/10/21
- Fly Intel: Top five weekend stock stories
- 10:13 Today JPMorgan
- JPMorgan says buy 'FANG' stocks amid 'fatigue and frustration'
- 09:52 Today
- Fly Intel: Top five analyst upgrades
- 07:28 Today KeyBanc
- Facebook price target raised to $345 from $340 at KeyBanc
- 05:02 Today BMO Capital
- Facebook upgraded to Outperform from Market Perform at BMO Capital
- 10/29/20
- Facebook sees Q4 ad revenue growth rate higher than Q3
- 10/29/20
- Facebook reports Q3 EPS $2.71, consensus $1.91
- 10/29/20
- Notable companies reporting after market close
- 07/30/20
- Facebook reports Q2 EPS $1.80, consensus $1.39
- 11:03 Today
- Instagram's Mosseri says removing Trump was the right decision, Verge says
- 06:08 Today
- WhatsApp delaying privacy policy by three months, The Verge reports
- 01/17/21
- Facebook to ban ads promoting weapon accessories, protective gear, Reuters says
- 01/15/21
- BlackBerry reports settlement with Facebook over patents, Bloomberg says
- 10:05 Today
- Facebook upgrade, Roku initiation among today's top calls on Wall Street
- 01/13/21
- #SocialStocks: Social Media cancels Trump, Amazon cuts off Parler
- 01/12/21
- NIO downgrade, Wells Fargo upgrade among today's top calls on Wall Street
- 01/11/21
- Fly Intel: Wall Street's top stories for Monday
- 01/15/21
- Facebook call volume above normal and directionally bullish
- 12/21/20
- Facebook call buyer realizes 33% same-day gains
- 12/10/20
- Unusually active option classes on open December 10th
- 12/07/20
- Facebook call volume above normal and directionally bullish
|